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ABSTRACT 
Gowns and drapes are used widely in healthcare facilities. 
Gowns have been used to minimize the risk of disease acquisition 
by healthcare providers, to reduce the risk of patient-to-patient 
transmission, and during invasive procedures to aid in maintaining 
a sterile field. Drapes have been used during invasive procedures 
to maintain the sterility of environmental surfaces, equipment, and 
patients. This article reviews the use of gowns and drapes in 
healthcare facilities, including the characteristics, costs, benefits, 
and barrier effectiveness of single-use and reusable products. 
Currently, gowns protect healthcare personnel performing 
invasive procedures from contact with bloodborne pathogens. 
Although gowns have been recommended to prevent patient-to-
patient transmission in certain settings (eg, neonatal intensive care 
unit) and for certain patients (eg, those infected with vancomycin-
resistant enterococci), scientific studies have produced mixed 
results of their efficacy. While appropriate use of drapes during 
invasive procedures is recommended widely as an aid in minimiz-
ing contamination of the operative field, the efficacy of this practice 
in reducing surgical-site infections has not been assessed by sci-
entific studies. 
Based on an evaluation of the functional requirements, envi-
ronmental impact, and economics of gowns and drapes, clear superi-
ority of either reusable or single-use gowns and drapes cannot be 
demonstrated. The selection of particular gowns and drapes by indi-
vidual healthcare facilities requires an assessment of the facility's 
requirements, available products, and costs and should be based on 
the desired characteristics of an ideal gown or drape as defined in 
this paper {Infect Control Hosp Epidemiol 2001;22:248-257). 
Gowns and drapes have been used for more than a 
century by healthcare professionals. Gowns have been 
used to minimize the risk of disease acquisition by health-
care providers, to reduce the risk of patient-to-patient 
transmission, and during invasive procedures to aid in 
maintaining a sterile surgical or procedure field. Drapes 
have been used during invasive procedures to maintain 
sterility of environmental surfaces, equipment, and 
patients. Modern technology allows gowns and drapes to 
be constructed of many materials. Healthcare facilities 
should understand the characteristics of the ideal gown or 
drape and base their purchase decisions by balancing 
health and safety concerns with economic, environmental, 
and comfort issues.1 
This article addresses important issues regarding 
gowns and drapes, including a consideration of their uses, 
characteristics of an ideal gown and drape, benefits, cost, 
environmental impact, and barrier effectiveness. 
USES OF G O W N S A N D DRAPES 
I N HEALTH CARE 
Gowns are used widely in healthcare facilities as part 
of personal protective equipment to minimize the passage 
of microbes to surgical patients and to minimize exposure 
of healthcare providers to infectious agents, especially 
bloodborne pathogens such as human immunodeficiency 
virus (HIV), hepatitis B virus, and hepatitis C virus. Drapes 
are used on patients during invasive procedures to elimi-
nate or minimize the passage of microorganisms from non-
sterile to sterile areas, thereby reducing the risk of noso-
comial infection. 
Healthcare providers are at risk for acquiring infec-
tion during patient-care activities, especially bloodborne 
pathogens during invasive procedures. The risks of acqui-
sition of hepatitis B,23 hepatitis C,4 and HIV5'6 have been 
well documented. All three pathogens can be acquired via 
contact of contaminated body fluids with nonintact skin or 
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mucous membranes. Because of these risks, the 
Occupational Safety and Health Administration (OSHA) 
promulgated a rule in 1991 to minimize healthcare work-
ers' risks of acquiring bloodborne pathogens.7 This rule 
required that employers provide healthcare workers with 
appropriate personal protective equipment (PPE). PPE is 
defined as specialized clothing or equipment for protection 
against pathogens. The rule lists examples such as gowns, 
laboratory coats, eye protection, masks, face shields, and 
gloves. The OSHA rule allows the employer and employee 
to select the PPE based on the type of exposure and the 
quantity or amount of body fluids that may be encountered 
during the performance of the task or procedure. The rule 
directs that blood or other potentially contaminated body 
fluids must not reach the employee's work clothes or street 
clothes, undergarments, skin, eyes, mouth, or other 
mucous membranes. This protection must last for the 
expected duration of the task or procedure. The type of 
PPE required depends on the following three factors: (1) 
the condition of exposure, which includes the part at risk 
(eg, face, legs, hands) and the type of the exposure (eg, 
pressure, fluids, droplets, aerosols); (2) the amount of 
blood or body fluid exposure (ie, a few drops to large vol-
umes of liquid); and (3) the duration of likely exposure (ie, 
short exposure, such as starting an intravenous line, or 
long exposure, such as cardiothoracic surgery). 
Nosocomial infections result in substantial morbidity 
and mortality. The Centers for Disease Control and 
Prevention (CDC) has estimated that nosocomial infections 
cause 19,027 deaths and contribute to an additional 58,092 
deaths per year. Surgical-site infections (SSIs) have been esti-
mated to cause 3,251 deaths directly and to contribute to 
9,726 deaths.8 Since the incidence of SSIs in the lowest-risk 
category of procedures is approximately 1% and an estimated 
27 million surgical procedures are performed each year, 
more than 270,000 SSIs are likely to occur each year. Multiple 
strategies have been recommended to reduce the incidence 
of SSIs, including the proper use of drapes to cover tables, 
equipment, and the patient, so as to create a sterile field dur-
ing an invasive procedure.1 Drapes most commonly are used 
during surgery, but they also are used for a variety of other 
invasive procedures, including cardiac catheterization, lum-
bar puncture, and placement of arterial or central venous 
access devices. Drapes are recommended by the CDC to 
reduce SSIs.9 Drapes also are recommended to prevent 
bloodstream infections during intravascular line insertion.10 
More recently, gowns have been evaluated as a 
means to reduce patient-to-patient transmission of resistant 
pathogens such as methicillin-resistant Staphylococcus 
aureus (MRSA) and vancomycin-resistant Enterococcus 
(VRE; see "Benefits" below). 
CHARACTERISTICS OF THE 
IDEAL GOWN OR DRAPE 
The characteristics of an ideal gown or drape have 
been well defined in the literature but not previously sum-
marized CTable l).11115 Each of these characteristics may 
be measured by one or more "standardized" tests.11 These 
standardized tests have been developed by several organi-
zations, including the American Society for Testing and 
Materials (ASTM; eg, ASTM F-1670, ASTM F-1671), the 
American Association of Textile Colorists and Chemists, 
the Health Industry Manufacturers Association, and the 
National Fire Prevention Association. Although a variety of 
tests have been used to compare barrier qualities of fabrics, 
there is controversy1617 about which test procedure most 
closely mimics actual conditions found in the surgical envi-
ronment. Current tests allow a broad categorization of 
gowns, based on increasing protection from liquid penetra-
tion: resistant (ie, resists penetration of liquids but will 
allow penetration with pressure), repellent (ie, resistance 
to wetting by a liquid), or impervious (ie, liquid-proof, pre-
vents the penetration of liquids and microorganisms). 
For reusable products, one must consider not only 
the characteristics of the purchased items but also the char-
acteristics of the laundered products. Maintaining manu-
facturers' specifications is easier for single-use items com-
pared with reusable products. 
AVAILABLE GOWNS AND DRAPES 
Surgical gowns and drapes are fabricated from either 
multiple- or single-use materials. These two basic types of 
products each have advantages and disadvantages. In addi-
tion, within each of these two broad categories, there is 
considerable variation in design and performance charac-
teristics which reflects the necessary trade-offs in econo-
my, comfort, and degree of protection required for particu-
lar surgical procedures.12 
Traditional Reusable Materials 
From the late 19th century to the 1970s, hospital sheet-
ing used cotton muslin as the primary fabric. During this era, 
three fabrics were commonly used. All-cotton muslin (140-
thread-count muslin) is a loosely woven fabric that is soft, 
absorbent, drapeable, and extremely porous. Since it is read-
ily permeable, this material does not possess any liquid-
resistance capability. Furthermore, it tends to abrade easily 
and generate lint Blended sheeting (180-thread-count per-
cale) consists of a polyester and cotton blended sheeting that 
has permanent press qualities but otherwise exhibits perfor-
mance similar to muslin. Finally, T280 barrier (175- to 280-
thread-count), a tightly woven cotton or polyester-and-cotton 
blended fabric, was the first reusable fabric with a water-
repellent chemical finish. However, resistance to liquid pene-
tration diminishes with repeated wash cycles.12 
In the 1980s, new surgical textiles with improved, 
multiple-use protective qualities were developed. Advances in 
these materials included more consistent barrier properties, 
reduced flammability, low lint generation, and extended dura-
bility. Two broad groups of products encompass all the known 
varieties currently available. The first is polyester sheeting, 
which consists of a tightly woven fabric made of continuous-
filament synthetic yarn that is chemically finished. The sec-
ond includes composite materials, combinations of woven or 
knitted fabrics engineered to obtain enhanced performance 
characteristics by laminating or coating them with various 
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TABLE 1 
CHARACTERISTICS OF AN IDEAL GOWN OR DRAPE 














































Ability to prevent penetration of contaminated liquids (ie, act as a repellent) and micro-
organisms. For reusable products, ability to maintain complete barrier effectiveness 
despite multiple washings. 
Prevent the greatest number of nosocomial infections. 
Consistent barrier effectiveness and reliability among all new products and, if used, 
among all reused products. 
Ability to allow wearer to perform activities without hindrance. 
Absence of heat fatigue in wearer, which may increase mistakes, impair performance, 
make the worker less efficient, and increase the employee's stress; allows moisture to 
evaporate quickly; nonallergenic. 
Low total cost, including acquisition cost per unit, storage cost, waste handling, laundry 
charges (reusable only), waste-disposal cost, potential liability (cost of gown failure), 
loss, and damage (reusable only). 
Ability to resist tears, which compromises the sterile field and allows penetration of 
microorganisms or liquids. 
Ability to resist punctures. 
Multiple sizes available (eg, small through extra large). 
Item must be capable of being sterilized, using standard methods (eg, ethylene oxide). 
Must consider local concerns regarding single-use versus reusable products (eg, landfill 
problems, water supply, stained reusable products). 
Ability to conform to patient or equipment contours smoothly and closely. 
Minimize linting. If linting occurs during a surgical procedure, lint may enter the wound 
increasing the risks for nosocomial infection and foreign-body reactions. 
Does not chemically irritate skin. 
Does not contain toxic materials. 
Flame-resistant fabrics preferred, especially for surgical drapes (ignition devices present 
in the OR include lasers, electro-surgical units, and hot-wire cauteries). However, all 
fabrics, including fire-resistant fabrics, will burn in an oxygen-enriched environment. 
Does not physically damage skin. 
Odor free. 
Minimize storage requirement. 
Self-contained procedure sets or surgical packs available, which decrease set-up time (single-
use only). 
Reusable: production, water, electricity to heat water, sewer, waste disposal. Single-use: 
production, waste disposal (landfill). 
Adheres to local and state solid-waste rules. Minimize total waste disposal. 
Contaminated drapes and gowns, if not properly managed, may represent a risk to per-
sons transporting or cleaning the contaminated item (reusable only). 
Abbreviation: OR operating room. 
types of films that provide increased protection against strike-
through of liquids and microorganisms.12 
Single-Use Materials 
Single-use surgical gowns and drapes are most com-
monly constructed of nonwoven materials, alone or in com-
bination with materials that offer increased protection from 
liquid penetration (eg, plastic films). Nonwoven fabrics are 
derived from various forms of natural (eg, wood pulp, cot-
ton) and synthetic fibers (eg, polyester, polyolefin) that can 
be engineered to achieve desired properties by the use of 
special fiber types, bonding processes, and fabric finishes. 
The three most commonly used nonwoven fabrics for sur-
gical gowns and drapes are spunlace, a hydroentangled 
material often consisting of wood pulp and polyester fibers; 
spunbond/meltblown/spunbond, a fabric consisting of 
three thermally or adhesively bonded layers (spunbond 
provides the strength, meltblown the barrier); and wet-laid, 
a nonwoven fabric consisting of wood pulp or a blend of 
polyester and wood-pulp fibers. The fibers are suspended 
in water to obtain a uniform dispersion and then are sepa-
rated from the slurry by draining the water through a fine 
mesh screen.12,13 Chemical treatments can be used to 
improve liquid penetration resistance. 
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Reinforcement of Reusable and 
Single-Use Products 
Both reusable and single-use products are common-
ly reinforced to enhance or improve their properties and 
performance. For some surgical gowns and drapes, the 
barrier properties of one ply (ie, single sheet or layer of fab-
ric) of a material may not be adequate for the particular 
application; in these cases, additional materials are often 
added in the form of additional layers of material, coating, 
reinforcements, or laminates. In addition, reinforcement 
may be added to improve absorbency and nonslippage or 
to produce other desirable characteristics.12 The following 
materials are being used in reusable and single-use prod-
ucts: standard (one layer) fabric; reinforced fabric (second 
layer of fabric used to reinforce base material); zone-
impervious fabric; and impervious fabric. 
For many years, gowns made from woven 140-count 
cotton muslin were the standard fabric. However, liquids 
and skin-cell fragments that ranged from 5 to 60 um could 
penetrate the threads of 140-count muslin easily, allowing 
contaminants to reach the patient. The barrier effective-
ness of woven materials has been improved by the devel-
opment of tighter wovens, liquid-repellent finishes, and 
new fabrics (100% polyester fiber). 
Another improvement in the reusable fabric area has 
been the development of layered fabric with a highly resis-
tant membrane between two layers of fabric. These new 
reusable materials provide good barrier protection on first 
use, but maintenance of these barrier properties is depen-
dent on controlling all variables during the reprocessing. 
Some studies have shown that the barrier capabilities of 
laundered reusable fabrics are diminished.18 
Liquid-proof protection is available with poly-
reinforced, nonwoven, single-use products and with some 
reusable products that incorporate membranes. For situa-
tions when resistant or repellent fabric is appropriate, unre-
inforced nonwoven and reusable gowns and drapes may be 
chosen. Highly resistant barriers are available with single-
use products made from nonwoven fabrics reinforced with 
polyethylene and layered reusables with membranes. 
Gowns must be selected to provide protection against liq-
uid strike-through for the anticipated pressures and blood 
loss. Some researchers suggest that, with the exception of 
head and neck surgery, plastic-film reinforced gowns are 
recommended for all surgical cases when the anticipated 
blood loss is >100 mL and the duration exceeds 2 hours. 
For most procedures with less than 100 mL of blood loss or 
duration less than 2 hours, reinforced gowns are recom-
mended. Plastic-reinforced gowns are suggested for use 
during procedures conducted in the abdominal area.19 
BENEFITS 
Gowns are used widely in the hospital in an attempt 
to reduce the risk of acquiring or transmitting nosocomial 
infections. The major uses of gowns are twofold. First, 
gowns are used in surgery and while performing invasive 
procedures, both to decrease the transmission of skin flora 
from the healthcare staff and to protect the staff against 
contact with potentially infective material, such as blood. 
Second, gowns are used when caring for patients with cer-
tain infectious disease (eg, MRSA, respiratory syncytial 
virus, and VRE) to aid in preventing cross-transmission. 
The usefulness of barrier precautions has been reviewed.20 
Role of Crowns During Surgery in Preventing 
Nosocomial Wound Infections 
The surgical site is the third most common site of 
nosocomial infections and accounts for approximately 15% 
of all nosocomial infections. The CDC estimated that in 
1992 SSIs resulted in a mean additional hospital stay of 7.3 
days at a mean cost of $3,152.8 The use of highly resistant 
gowns and drapes in the operating room has been a stan-
dard infection control practice to prevent SSIs, because 
they act as barriers to bacteria that are shed by the patient 
or the surgical team members into the open wound during 
the operation.21 The CDC recently published a guideline 
providing science-based recommendations for prevention 
strategies to reduce the incidence of SSIs.9 This guideline 
made the following recommendation regarding surgical 
attire and drapes: "use sterile surgical gowns and drapes 
that are effective barriers when wet (ie, materials that 
resist liquid penetration)." This recommendation was 
ranked as a category IB, strongly recommended for imple-
mentation and supported by some experimental, clinical, or 
epidemiological studies and strong theoretical rationale. 
Six prospective studies (Table 2), all but one conduct-
ed prior to 1990, have compared the use of nonwoven and 
woven cotton gown and drape fabric to prevent intraoperative 
wound infections.2126 All studies were conducted in a 
prospective fashion. Assignment to reusable versus single-
use gowns and drapes differed among the studies and includ-
ed random assignment, crossover design, and pre- and post-
initiation of a disposable draping system. Some, but not all, 
studies used personnel who were masked as to the type of 
gown used for assessing the outcome variable (ie, wound 
infection). The study by Dr. Garibaldi was relatively small, but 
the authors used intraoperative wound contamination as their 
primary outcome measure, which effectively increased the 
power of the study.21 They reported that there was only a 10% 
probability that they would have missed a significant differ-
ence between single-use and reusable gowns, if such a differ-
ence truly existed. Several large studies have reported high-
er infection rates (relative risk>2.0) associated with reusable 
fabrics.222425 Dr. Moylan and colleagues reported a logistic 
model using postoperative infection as the dependent vari-
able and five predictors: type of gown (single-use vs 
reusable), wound category, length of operation, gender, and 
antibiotics.24 In both this model and the model including 
interaction terms, use of reusable gowns and drapes was 
associated with a significantly higher rate of SSIs. These stud-
ies stand in contrast to the prospective, randomized, masked 
study of Dr. Garibaldi and colleagues, which was unable to 
demonstrate a difference in either SSIs or wound contamina-
tion between reusable and single-use gowns and drapes.21 
Methodological flaws potentially present in these earlier stud-
ies included lack of true randomization, inadequate descrip-
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tion of the products tested, failure to account for all patients 
enrolled, failure to assure that reusable products were used 
within their life-expectancy, assessment of the primary out-
come (ie, SSI) by personnel aware of the subject's interven-
tion, and improper statistical tests. 
Recently, Bellchambers and coworkers reported a 
prospective, randomized, masked study that compared 
reusable gowns and drapes to single-use items in patients 
undergoing coronary artery bypass surgery.26 No differ-
ence in the rates of sternal or leg-wound infections between 
the groups was noted. A logistic regression of risk factors 
for sternal wound infection revealed that body mass index 
(P=.004) and duration of surgery (P=.02), but not type of 
gown or drape used (P=.73), was associated with sternal 
wound infections. 
Additional studies using currently available single-use 
gowns and drapes versus reusable gowns are required to 
assess the clinical impact of single-use versus reusable 
gowns. Such studies should be prospective and randomized, 
with independent assessment of outcomes. In addition, other 
variables such as antimicrobial prophylaxis, surgical scrubs, 
preoperative showers, and hair-removal methods must be 
standardized. Such studies should assess other factors, such 
as healthcare provider comfort, relative costs, other eco-
nomic measures, and environmental impact 
Role of Crowns in Preventing Cross-Transmission 
of Nosocomial Pathogens 
The CDC has provided recommendations for the 
proper isolation of patients with infectious diseases.27 This 
guideline states that "gowns are worn by personnel during 
the care of patients infected with epidemiologically impor-
tant microorganisms to reduce the opportunity for transmis-
sion of pathogens from patients or items in their environ-
ment to other patients or environments." Gowns should be 
worn for specified patients known or suspected to be infect-
ed or colonized with epidemiologically important microor-
ganisms that can be transmitted by direct contact with the 
patient (hand or skin-to-skin contact that occurs while per-
forming patient-care activities that require touching the 
patient's dry skin) or indirect contact (touching) with envi-
ronmental surfaces or patient-care items in the patient's envi-
ronment. The guideline states that the gown (a clean, non-
sterile gown is adequate) should be worn when entering the 
room if one anticipates that clothing will have substantial 
contact with the patient, environmental surfaces, or items in 
the patient's room, or if the patient is incontinent or has diar-
rhea, an ileostomy, a colostomy, or wound drainage not con-
tained by a dressing. The gown should be removed prior to 
leaving the patient's environment After gown removal, one 
should ensure that clothing does not contact potentially con-
taminated environmental surfaces to avoid transfer of 
microorganisms to other patients or environments. 
Infections for which gowns are recommended include drain-
ing abscesses, adenovirus infection in children, varicella, 
zoster, congenital rubella, cutaneous diphtheria, certain viral 
hemorrhagic fevers, Clostridium difficile colitis, multidrug-
resistant pathogens (eg, VRE, MRSA), pediculosis and other 
ectoparasites, respiratory syncytial virus (RSV) in children 
or immunocompromised adults, and major S aureus or strep-
tococcal skin or wound infections. The guideline does not 
specify what types of gowns should be worn. It also notes 
that adequate data regarding the efficacy of gowns to pre-
vent cross-transmission are not available. 
Gowns or cover gowns have been used for years in 
hospital newborn units in the belief that they reduce cross-
transmission. Studies, including those that have used a ran-
domized design, have demonstrated no benefit to the rou-
tine use of cover gowns on postpartum units for healthy 
full-term infants.28"31 Specifically, the incidence of nasal and 
umbilical colonization with S aureus is not altered by the 
use of cover gowns.30'31 
As in newborn units, cover gowns have been widely 
used in neonatal intensive care units.32 Multiple prospective 
studies have failed to demonstrate that the routine use of 
cover gowns in this setting decreased bacterial colonization 
of the infants, overall nosocomial infection rates, or the inci-
dence of intravenous catheter colonization.3335 However, 
Agbayani and colleagues reported a randomized trial that 
found that necrotizing enterocolitis occurred more fre-
quently during a modified gowning period than in the 
gowning period, but were unable to show any consistent 
difference in colonization, mortality, or infection rates.36 
Klein and coworkers also reported a reduction in nosoco-
mial infections during pediatric intensive care when pro-
tective isolation (which included protective, high-barrier 
gowns and gloves) was used.37 
Respiratory syncytial virus represents a serious noso-
comial hazard, especially for infants with cardiorespiratory 
diseases or immunodeficiency states. The virus is spread by 
close contact with infected secretions, by large-particle 
aerosols, and by fomites. Small-particle aerosols do not seem 
to be a major route of transmission. Hospital personnel are 
thought to be the main vector, transmitting the virus on con-
taminated hands and even becoming infected themselves by 
self-inoculation of mucous membranes. Control measures 
have included hand washing, gloves, gowns, cohorting RSV-
infected patients, face masks, and eye-nose goggles. 
Compliance with both glove and gown use has been demon-
strated to reduce the rate of nosocomial RSV infection among 
children.38 A later prospective study demonstrated that the 
combination of cohort nursing and glove and gown use 
decreased the risk of RSV transmission but that the use of 
gowns and gloves alone or cohort nursing alone failed to pro-
duce a significant reduction in cross-transmission.39 
The incidence of nosocomial infections due to MRSA 
and VRE has dramatically increased in recent years. 
Control of VRE outbreaks has been achieved by instituting 
multiple infection control interventions, including the use 
of disposable gowns when entering the rooms of patients 
with known or suspected colonization.4041 However, a con-
trolled clinical trial failed to demonstrate that the universal 
use of gloves and gowns was superior to the universal use 
of gloves alone in preventing rectal colonization by VRE 
patients in a medical intensive care unit42 It has been sug-
gested that the failure to demonstrate that gown use 
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reduced VRE cross-transmission in this study may have 
been due to the lack of heavy environmental contamina-
tion.43 Further studies are needed to determine when the 
routine use of gowns by personnel provides added protec-
tion against the spread of VRE. 
ENVIRONMENTAL IMPACT OF 
GOWNS AND DRAPES 
Both single-use and reusable gowns and drapes have 
an environmental impact. The environmental impact has 
been evaluated in an independent report prepared by 
Arthur D. Little and commissioned by Johnson & 
Johnson.44 The Little report developed a product life-cycle 
inventory that allowed comparison of the environmental 
impact of single-use versus reusable gowns and drapes. 
The life cycle included resource inputs (energy, water, raw 
materials); life-cycle stages (raw material acquisition, man-
ufacturing, transportation, use/reuse/maintenance, and 
waste management); and environmental outputs (water pol-
lutants, air pollutants, solid and hazardous wastes). An 
analysis of the inventory results showed that neither the 
single-use nor the reusable products studied were clearly 
superior from an environmental standpoint. The single-use 
products consume more raw materials and energy and gen-
erate more solid waste than the reusable products. Most of 
the air emissions (nitrogen oxides, sulfur oxides, and par-
ticulates) from manufacture and transport of both types of 
products result from energy production; hence, the single-
use products produce more energy-related air emissions. 
These types of air emissions are associated with the air pol-
lution resulting in acid rain. The reusable products con-
sume substantially more water and produce more water 
pollution. They also generate more volatile organic com-
pounds as air emissions. Volatile organic compound emis-
sions generally are associated with smog levels in the 
atmosphere. As the Little report notes, it is difficult to place 
judgment on which types of environmental burdens are 
more important or damaging to the ecology.44 
Currently, approximately 80% of hospitals in the 
United States have chosen to use single-use gowns. The 
cost of disposal will be determined, in part, by whether 
blood-contaminated gowns and drapes constitute "regulat-
ed medical wastes" that would require additional and more 
costly methods of disposal. Whether blood-contaminated 
gowns and drapes are considered regulated medical waste 
varies among the different states. In states that do not clas-
sify blood-contaminated gowns or drapes as regulated med-
ical waste (eg, North Carolina), it is crucial for healthcare 
facilities to segregate these items separately from regulat-
ed medical wastes to achieve cost savings. However, nei-
ther the CDC nor the Environmental Protection Agency 
provide detailed guidance on whether blood-contaminated 
gowns and drapes should be considered regulated medical 
waste. 
Overall, hospital waste accounts for 2% of national 
municipal wastes. Gowns and drapes contribute approxi-
mately 2% of all hospital waste. Thus, gowns and drapes 
constitute approximately 0.04% of all municipal wastes.44 
COSTS ASSOCIATED WITH REUSE 
The Little report commissioned by Johnson & 
Johnson also addressed the economic impact of reusable 
versus single-use gowns and drapes. This economic analysis 
considered five cost components: direct costs, drape set-up 
and changing costs, laundering and reprocessing costs, stor-
age and inventory costs, and disposal costs. For single-use 
items, direct purchase cost was the most important factor 
(approximately 90% of total costs); factors that had an impact 
on costs of reusable items included the number of reuses, 
laundering and reprocessing costs (75%-95% of total cost), 
and number of drapes used per procedure. Interestingly, dis-
posal costs for single-use items averaged only 4% to 5% of the 
total costs. Applying this analysis (1991 dollars) to an aver-
age single abdominal operation revealed that the total cost 
for drapes was $18 and for gowns was $10, with similar cost 
whether single-use or reusable items were used.44 
An important factor to consider in cost estimates of 
reusable gowns is the standard allowance for loss and dam-
age, which often runs approximately 2%. Reusable gowns 
and drapes may be discarded improperly. Operating room 
gowns may be removed from the healthcare facility for per-
sonal use. The approximate cost of a single-use gown is $3 to 
$7, whereas the approximate cost of a reusable reinforced 
gown is «$60.45 While some manufacturers predict 75 uses, 
a hospital's loss, damage (tears, holes), and resistance to 
blood and viral penetration for 75 launderings or steriliza-
tions may drastically reduce the garment's life span and 
increase the cost per procedure. A loss rate of 2% may not 
seem important, but it will have a substantial impact on the 
life of the product. For example, a reusable gown with an 
engineered life of 80 uses in an environment with a 2% loss 
or damage rate will have an actual life of only 41 uses (ie, 
about a 50% shortened life expectancy). 
The actual costs associated with disposable versus 
reusable scrub suits and gowns in the operating room have 
been evaluated. Comparing two hospitals, DiGiacomo and 
colleagues concluded that reusable scrub suits and gowns 
would result in cost savings in excess of $100,000 (1990 dol-
lars) compared to using disposables.46 However, single-use 
scrub suits have not been proposed, and the inclusion of 
scrub suits skews the data in favor of reusables. In contrast, 
Moylan24 (Table 3) and Murphy47 showed lower costs with 
the use of disposable gowns and drape systems. A cost-
effectiveness analysis of current reusable versus dispos-
able products should be undertaken using accepted cost-
effectiveness analysis methodologies. 
BARRIER EFFECTIVENESS 
OF GOWNS AND DRAPES 
Multiple difficulties have been described in the liter-
ature regarding the evaluation of the barrier effectiveness 
of surgical gowns. First, surgical gowns are used for two 
main purposes: to minimize contamination of the operating 
room environment by microbial skin flora of participating 
healthcare workers and to prevent skin or clothing contact 
by the healthcare team with potentially infective patient 
material, especially bloodborne pathogens (eg, HIV, hepati-
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tis B virus). Hence, multiple tests to evaluate barrier effec-
tiveness are required. Second, despite the publication of 
standardized methods for determining the barrier effective-
ness of gowns, universal acceptance of these standardized 
tests does not exist. Most methods rely on a soak-through of 
liquids. Third, viral penetration of gowns may occur in the 
absence of obvious soak-through. Fourth, laboratory testing 
may not mimic actual in-use testing. Specifically, certain 
areas of the body are subject to stress and pressure, result-
ing in increased permeability. Finally, the multitude of prod-
ucts and changes in product design makes generalizations 
regarding comparative effectiveness difficult. 
Multiple test methodologies for assessing the barrier 
effectiveness of gowns and drapes have been described. 
These can be divided into tests of fabric characteristics (eg, 
composition, thickness, air permeability, and water-vapor 
transmission rate); liquid-barrier properties (eg, mason jar 
test, penetration of liquids upon impact, hydrostatic pres-
sure tests); and penetration by microorganisms, which may 
be aerosolized or contained in liquid. Tests of liquid pene-
tration may use a variety of liquids, including water, syn-
thetic blood, or human blood. Some tests are qualitative, 
providing only a positive or negative result, whereas others 
provide quantitative results. 
The viral penetration of surgical gowns by HIV has 
been compared to the soak-through point by multiple inves-
tigators.48'49 Both studies reported that HIV could penetrate 
some surgical-gown materials in common use at the time of 
the studies. Further, HIV penetration was sometimes noted 
in the absence of visible soak-through. 
Because certain areas of the body are subject to 
stress and pressure resulting in increased permeability, 
Beck and Collette50 and Bernard and Beck51 have suggest-
ed that gowns should be tested both in the laboratory set-
ting and under conditions of use. Simulated surgical move-
ments (ie, leaning, reaching, arm resting) have been found 
to develop less than 2 psi pressure.45 Using a 32-sensor mat 
placed in the abdominal area of a surgeon during operative 
procedures, Smith and colleagues demonstrated that pres-
sure contacts were frequent, generally less than 2.9 psi, and 
lasted less than 15 seconds.52 Liquid strike-through has 
been demonstrated in laboratory tests to be both pressure-
and time-dependent.4553 The importance of pressure in 
leading to strike-through has been demonstrated by evalu-
ating gowns after clinical use in surgical procedures. An 
evaluation of blood strike-through during 234 surgical pro-
cedures revealed that strike-through was related to the 
extent of contamination on the outside of the gown and was 
heavy in areas of the gown subjected to stress or pressure 
(ie, chest, forearm, abdomen).54 Pissiotis and coworkers 
observed the following rates of strike-through: reusable 
gowns, 90%; disposable single-layer gowns, 11%; and dis-
posable reinforced gowns, 3%.55 The areas most vulnerable 
to strike-through were the cuff, forearm, thigh, chest, and 
abdomen. Ahmad and colleagues demonstrated the follow-
ing failure rates of gowns to prevent blood strike-through in 
obstetrical procedures: single-layer nonwoven fabric, 
55.8%; reinforced fabric, 26.7%; reinforced fabric with high-
ly resistant fabric in chest and forearms, 21.1%; and full 
length with impervious front panel and forearms and ther-
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mally sealed side seams, 16.796.56 Prolonged contact of 
gowns with blood may result in increased permeability 
when external pressure is applied.57 A recent study of mul-
tiple hospitals in Germany demonstrated that deficiencies 
could be observed in the processed items (eg, 58% had 
holes in one or more individual items).58 
Bearing in mind the above-mentioned difficulties in 
assessing the comparative barrier effectiveness of gowns, 
recent studies allow the following generalizations.45'49'53'59*2 
Fabric characteristics, such as construction, repellency, and 
pore size, contribute to gown performance. Laminates or 
polypropylene-treated gowns (eg, 97%-100% polypropylene, 
spunbond/meltblown/spunbond laminates) provide the 
greatest protection against blood strike-through and bacteri-
al penetration. Gowns composed of a single layer of non-
woven fabric provide the next greatest effectiveness. Gowns 
composed of 100% woven cotton, used on reusable products, 
provided the least protection. Individual products may vary 
greatly, and these conclusions are only generalizations. 
The cumulative effect of laundering on the barrier 
efficacy of reusable cotton gowns has been studied by sev-
eral investigators.1853 In general, reusable gowns provided 
less protection than new gowns.18'45,61 Leonas reported that 
reusable gowns with a single layer of fabric demonstrated an 
increased amount of bacteria transmitted through the fabric 
after laundering, whereas those reinforced with a second 
fabric layer did not.18 Granzow reported that washed 
reusable gowns composed of 100% woven cotton were some-
what more effective in preventing blood strike-through and 
passage of S aureus than new reusable gowns.53 However, 
Belkin noted that this finding is likely attributable to the 
apparently loosely woven, readily permeable, 100% cotton 
fabric shrinking during the laundry process (es), and the 
tightening up of the (warp and fill) yarns.63 
CONCLUSION 
Appropriate gowns are useful to prevent exposure to 
bloodborne pathogens by healthcare workers. The use of 
gowns to prevent patient-to-patient transmission of nosoco-
mial pathogens remains controversial, because studies 
assessing the efficacy of gowns have produced mixed 
results. The use of drapes in invasive procedures is widely 
recommended, for theoretical reasons, to minimize micro-
bial contamination of the surgical site, although modern 
scientific studies have not assessed the efficacy of barrier 
protection in this setting. 
Older studies suggested that single-use gowns and 
drapes used during surgical procedures were superior to 
reusable products in preventing SSIs. These studies have 
limited relevance because of methodological flaws and 
product improvements. Only limited data are available 
regarding currently available products. In conclusion, a 
clear superiority of currently available single-use gowns 
and drapes versus reusable products has not been demon-
strated based on efficacy to prevent infections, environ-
mental impact, or economics. The selection of particular 
gowns and drapes by individual healthcare facilities 
requires an assessment of the facility's requirements, avail-
able products, and costs, and should be based on the 
desired characteristics of an ideal gown or drape. 
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Vancomycin Use and VRE Colonization in Dialysis Patients 
Gina Pugliese, RN, MS 
Martin S. Favero, PhD 
Vancomycin is widely used with 
hemodialysis patients as empirical therapy 
for dialysis-associated infections. To deter-
mine the relation of this practice to the 
generation of vancomycin-resistant entero-
coccal (VRE) colonization, Atta and coin-
vestigators from Johns Hopkins in 
Baltimore, Maryland, conducted a 2-year 
prospective cohort study. Cultures for 
VRE were taken from rectal swabs 
obtained from patients at the start and fin-
ish of the study period and during interim 
hospitalizations. 
The results showed that 10 of 124 
patients initially grew VRE. Twenty-four 
of the remaining patients had no follow-
up cultures because of patient death 
(62%), transfer to another dialysis facility 
(17%), patient's refusal (7%), and trans-
plantation (4%), and thus were excluded. 
The remaining patients (n=90) had a 
median age of 54.3 years and were 92% 
African American and 50% male. Fifty-
eight percent were treated by hemodialy-
sis. They received 403 g of intravenous 
vancomycin over 157.2 patient-years of 
follow-up, 73% as outpatients. 
Sixteen (17.8%) of 90 patients 
became colonized with VRE, an incidence 
rate of one case per 9.8 patient-years of fol-
low-up. None of the 29 patients who did 
not receive vancomycin developed VRE, 
compared with 26% of those treated with 
vancomycin (P=.001). The odds ratio (95% 
confidence interval) for the association of 
outpatient vancomycin (g/y) with VRE col-
onization was 1.23 (1.05,1.44, P=.008). The 
association remained significant following 
adjustment in separate logistic regression 
analyses for relevant demographic, clini-
cal, antimicrobial (inpatient vancomycin, 
oral or intravenous cephalosporins, amino-
glycosides, quinolones, or anti-anaero-
bics), and hospitalization exposures. The 
unadjusted relative risk of death in 
patients growing VRE was significantly 
higher than in those not colonized with 
VRE (P=.005). 
The authors concluded that VRE col-
onization is a relatively common and 
underrecognized problem among chronic 
dialysis patients and is strongly and inde-
pendently associated with the outpatient 
use of vancomycin, which should be avoid-
ed whenever possible. 
FROM: Atta MG, Eustace JA, Song 
X, Perl TM, Scheel PJ. Outpatient van-
comycin use and vancomycin-resistant 
enterococcal colonization in maintenance 
dialysis patients. Kidney Int 2001;59: 
718-724. 
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